Both vatreptacog alfa and rFVIIa gave @ % effective bleeding control at @ h. Vatreptacog alfa was superior to rFVIIa in secondary efficacy outcomes , including the number of doses used to treat a bleed and sustained bleeding control @-@ h after the first dose .